Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|9|2|139-147

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.9, Iss.2, 2014-05, pp. : 139-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel plus oral metronomic cyclophosphamide: A phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patients

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3923-3931

Blackwell Publishing

Access to resources Recommend Favorite

Trastuzumab plus docetaxel in metastatic breast cancer

By  

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone

By Paz-Ares Luis  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 729-740

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

By Kim Sun   Hong Yong   Kim Byung   Park Ji   Choi Hyo   Jeong Seung-Yong   Kim Dae   Hong Chang   Sohn Dae   Jung Kyung  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 269-274

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Study of 9-Nitro-Camptothecin in Patients with Previously Treated Metastatic Breast Cancer

By Miller Kathy D.   Soule Sharon E.   Haney LaTrice G.   Guiney Patricia   Murry Darryl J.   Lenaz Luigi   Sun Show-Li   Sledge Jr George W.  

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 69-73

Springer Publishing Company

Access to resources Recommend Favorite